AUDYF logo

Ausnutria Dairy Corporation Ltd (AUDYF)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Ausnutria Dairy Corporation Ltd (AUDYF) with AI Score 47/100 (Weak). Ausnutria Dairy Corporation Ltd specializes in the production and distribution of infant formula and dairy products. Market cap: 0, Sector: Consumer defensive.

Last analyzed: Mar 16, 2026
Ausnutria Dairy Corporation Ltd specializes in the production and distribution of infant formula and dairy products. The company operates globally, with a focus on both cow and goat milk-based formulas.
47/100 AI Score

Ausnutria Dairy Corporation Ltd (AUDYF) Consumer Business Overview

CEOZhijian Ren
Employees3288
HeadquartersSheung Wan, HK
IPO Year2021

Ausnutria Dairy Corporation Ltd is a global packaged foods company focused on infant formula and dairy products, differentiating itself through its goat milk-based Kabrita brand and a diversified geographic presence spanning China, Europe, and other international markets. The company operates in the consumer defensive sector.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 16, 2026

Investment Thesis

Ausnutria Dairy Corporation Ltd presents a mixed investment thesis. The company's focus on infant formula, particularly its goat milk-based Kabrita brand, offers differentiation in a competitive market. A P/E ratio of 16.83 suggests a reasonable valuation, while a dividend yield of 3.09% provides income potential. However, a relatively low profit margin of 3.2% indicates potential challenges in profitability. Growth catalysts include expanding its geographic presence and product diversification into nutrition and probiotic products. Potential risks include fluctuating raw material costs and changing consumer preferences in the infant formula market. Investors should closely monitor the company's ability to improve profitability and maintain its market share in key regions.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market capitalization of $0.46 billion indicates its size relative to competitors in the packaged foods industry.
  • P/E ratio of 16.83 suggests a potentially reasonable valuation compared to industry peers.
  • Gross margin of 41.0% reflects its ability to manage production costs and maintain pricing power.
  • Dividend yield of 3.09% offers an income component for investors.
  • Beta of 0.47 suggests lower volatility compared to the overall market, which may appeal to risk-averse investors.

Competitors & Peers

Strengths

  • Strong brand recognition for Kabrita goat milk-based formula.
  • Diversified geographic presence across key markets.
  • Established research and development capabilities.
  • Comprehensive product portfolio including cow and goat milk-based formulas.

Weaknesses

  • Relatively low profit margin compared to competitors.
  • Dependence on the infant formula market, which is subject to regulatory changes.
  • Limited brand awareness compared to larger multinational corporations.
  • Exposure to fluctuating raw material costs.

Catalysts

  • Ongoing: Expansion into new geographic markets, particularly in Asia and South America, driving revenue growth.
  • Ongoing: Product diversification into related nutrition and health products, increasing market reach.
  • Ongoing: Increased penetration in the e-commerce channel, enhancing customer engagement and sales.
  • Upcoming: Potential strategic partnerships and acquisitions to expand market share and product portfolio.
  • Ongoing: Continued focus on research and development to innovate and improve existing product lines.

Risks

  • Ongoing: Intense competition from established players in the infant formula market, potentially impacting market share.
  • Potential: Changing consumer preferences and dietary trends, requiring continuous adaptation and innovation.
  • Ongoing: Stringent regulatory requirements and product safety standards, increasing compliance costs.
  • Potential: Potential for product recalls or safety concerns, damaging brand reputation and financial performance.
  • Potential: Fluctuations in raw material costs, impacting profitability.

Growth Opportunities

  • Expansion in Southeast Asia: Ausnutria has the opportunity to further expand its presence in Southeast Asia, capitalizing on the region's growing middle class and increasing demand for infant formula. The infant formula market in Southeast Asia is projected to reach $15 billion by 2028, offering a substantial growth runway for Ausnutria. Success will depend on adapting products to local preferences and establishing strong distribution networks.
  • Product Diversification into Probiotics: Ausnutria can leverage its existing infrastructure and brand reputation to expand its product offerings into probiotics. The global probiotics market is expected to reach $91.09 billion by 2032, presenting a significant opportunity for Ausnutria to diversify its revenue streams. This expansion aligns with the growing consumer interest in health and wellness products.
  • Increased Penetration in the European Union: Ausnutria can focus on increasing its market share in the European Union by leveraging its existing distribution channels and introducing new product variations. The EU infant formula market is characterized by high quality standards and discerning consumers, requiring Ausnutria to maintain product excellence and effective marketing strategies. This market is projected to grow steadily, driven by increasing birth rates and rising disposable incomes.
  • Strategic Partnerships and Acquisitions: Ausnutria can pursue strategic partnerships and acquisitions to expand its product portfolio and geographic reach. Collaborating with local distributors or acquiring smaller competitors can provide access to new markets and technologies. This strategy can accelerate growth and enhance Ausnutria's competitive position in the global dairy market.
  • E-commerce Channel Development: Ausnutria can invest in developing its e-commerce channels to reach a wider customer base and enhance its brand visibility. The online retail market for infant formula is growing rapidly, driven by increasing internet penetration and changing consumer shopping habits. A strong e-commerce presence can improve customer engagement and drive sales growth.

Opportunities

  • Expansion into new geographic markets, particularly in Asia and South America.
  • Product diversification into related nutrition and health products.
  • Increased penetration in the e-commerce channel.
  • Strategic partnerships and acquisitions to expand market share.

Threats

  • Intense competition from established players in the infant formula market.
  • Changing consumer preferences and dietary trends.
  • Stringent regulatory requirements and product safety standards.
  • Potential for product recalls or safety concerns.

Competitive Advantages

  • Brand recognition, particularly for its Kabrita goat milk-based formula.
  • Established distribution network across multiple regions, including China and Europe.
  • Research and development capabilities for developing innovative dairy and nutrition products.
  • Proprietary formulations and manufacturing processes.

About AUDYF

Founded in 2003 and headquartered in Sheung Wan, Hong Kong, Ausnutria Dairy Corporation Ltd is an investment holding company engaged in the research, development, production, and distribution of infant formula and other dairy products. The company operates through two segments: Dairy and Related Products, and Nutrition Products. Ausnutria offers a range of cow milk-based infant formula products under brands such as Allnutria, Hyproca Hollary, Hyproca Hypure, Neolac, and Puredo. A key differentiator is its goat milk-based infant formula, marketed under the Kabrita brand. Ausnutria also engages in original equipment manufacturing (OEM) for formula milk powder products. Additionally, the company manufactures and distributes nutrition products, develops and sells probiotic products, and provides financing services. Its geographic footprint is extensive, covering the People's Republic of China, the European Union, Southeast Asia, Australia, New Zealand, the Middle East, North and South America, and other international markets. Ausnutria Dairy Corporation Ltd operates as a subsidiary of HongKong Jingang Trade Holding Company Limited.

What They Do

  • Researches and develops infant formula and dairy products.
  • Collects and processes milk.
  • Produces and packages infant formula and dairy products.
  • Markets and distributes its products globally.
  • Manufactures formula milk powder products on an original equipment manufacturing (OEM) basis.
  • Develops, distributes, and sells probiotic products.
  • Provides financing services.

Business Model

  • Produces and sells cow milk-based infant formula under brands like Allnutria and Neolac.
  • Produces and sells goat milk-based infant formula under the Kabrita brand.
  • Generates revenue through the sale of nutrition and probiotic products.
  • Provides OEM services for formula milk powder products.

Industry Context

Ausnutria Dairy Corporation Ltd operates within the global packaged foods industry, specifically focusing on the infant formula and dairy products segment. This industry is characterized by intense competition, evolving consumer preferences, and stringent regulatory oversight. The global infant formula market is projected to grow, driven by increasing birth rates in developing countries and rising disposable incomes. Ausnutria's focus on goat milk-based formula positions it within a niche market that caters to specific dietary needs and preferences. Competitors include major players such as ARZTY (Arla Foods), GKSDF (Nestle), and GRGSF (Danone), requiring Ausnutria to maintain product innovation and effective marketing strategies to sustain its market share.

Key Customers

  • Infants and young children requiring formula feeding.
  • Parents and caregivers seeking nutritional products for their children.
  • Retailers and distributors selling infant formula and dairy products.
  • OEM partners requiring formula milk powder production.
AI Confidence: 71% Updated: Mar 16, 2026

Financials

Chart & Info

Ausnutria Dairy Corporation Ltd (AUDYF) stock price: Price data unavailable

Latest News

No recent news available for AUDYF.

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AUDYF.

Price Targets

Wall Street price target analysis for AUDYF.

MoonshotScore

47/100

What does this score mean?

The MoonshotScore rates AUDYF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Zhijian Ren

CEO

Zhijian Ren serves as the CEO of Ausnutria Dairy Corporation Ltd. Information regarding Mr. Ren's detailed career history, educational background, and previous roles is not available in the provided data. His leadership is pivotal in guiding Ausnutria's strategic direction and overseeing its global operations within the competitive dairy and nutrition industry.

Track Record: Due to limited information, Zhijian Ren's specific achievements, strategic decisions, and company milestones under his leadership cannot be detailed. His role involves managing 3288 employees and navigating the company through the dynamic landscape of the infant formula and dairy market.

AUDYF OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Ausnutria Dairy Corporation Ltd may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance compared to companies listed on major exchanges such as the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the potential for less transparency and regulatory oversight.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Liquidity for AUDYF on the OTC market is likely limited. OTC stocks generally have lower trading volumes and wider bid-ask spreads compared to exchange-listed stocks. This can make it more challenging to buy or sell shares quickly and at desired prices. Investors may experience difficulty in executing large trades without significantly impacting the stock price. The lack of liquidity can also increase price volatility and the potential for market manipulation.
OTC Risk Factors:
  • Limited financial disclosure increases the risk of investing in AUDYF.
  • Lower liquidity can lead to difficulty in buying or selling shares.
  • Potential for higher price volatility due to limited trading volume.
  • Less regulatory oversight compared to exchange-listed companies.
  • Increased risk of fraud or market manipulation.
Due Diligence Checklist:
  • Verify the company's financial statements and audit reports.
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's regulatory compliance and legal standing.
  • Monitor the company's news and press releases for any red flags.
  • Consult with a financial advisor before investing.
  • Understand the risks associated with investing in OTC stocks.
Legitimacy Signals:
  • Established presence in the infant formula and dairy market.
  • Global distribution network across multiple regions.
  • Focus on research and development of innovative products.
  • Operation as a subsidiary of HongKong Jingang Trade Holding Company Limited.
  • Market capitalization of $0.46 billion suggests a degree of scale.

Ausnutria Dairy Corporation Ltd Stock: Key Questions Answered

What does Ausnutria Dairy Corporation Ltd do?

Ausnutria Dairy Corporation Ltd is a global company focused on the production and distribution of infant formula and other dairy products. The company operates through two segments: Dairy and Related Products, and Nutrition Products. It offers both cow milk-based and goat milk-based infant formula products under various brand names, including Allnutria, Neolac, and Kabrita. Additionally, Ausnutria manufactures and distributes nutrition products, develops and sells probiotic products, and provides OEM services for formula milk powder products. The company's products are sold in the People's Republic of China, the European Union, Southeast Asia, and other international markets.

What do analysts say about AUDYF stock?

AI analysis is pending for AUDYF. Therefore, a neutral summary of analyst consensus, key valuation metrics, and growth considerations cannot be provided at this time. Investors should seek updated analyst reports and conduct their own due diligence to assess the potential risks and rewards of investing in AUDYF. Further research into the company's financial performance, market position, and growth prospects is recommended.

What are the main risks for AUDYF?

Ausnutria Dairy Corporation Ltd faces several risks, including intense competition in the infant formula market from established multinational corporations. Changing consumer preferences and dietary trends could impact demand for its products. Stringent regulatory requirements and product safety standards pose compliance challenges and potential for product recalls. Fluctuations in raw material costs can affect profitability. Additionally, the company's reliance on the Chinese market exposes it to regulatory and economic risks specific to that region.

What are the key factors to evaluate for AUDYF?

Ausnutria Dairy Corporation Ltd (AUDYF) currently holds an AI score of 47/100, indicating low score. Key strength: Strong brand recognition for Kabrita goat milk-based formula.. Primary risk to monitor: Ongoing: Intense competition from established players in the infant formula market, potentially impacting market share.. This is not financial advice.

How frequently does AUDYF data refresh on this page?

AUDYF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven AUDYF's recent stock price performance?

Recent price movement in Ausnutria Dairy Corporation Ltd (AUDYF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Strong brand recognition for Kabrita goat milk-based formula.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider AUDYF overvalued or undervalued right now?

Determining whether Ausnutria Dairy Corporation Ltd (AUDYF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying AUDYF?

Before investing in Ausnutria Dairy Corporation Ltd (AUDYF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Limited information available for CEO track record and OTC disclosure level.
  • AI analysis pending, limiting comprehensive analyst perspective.
Data Sources

Popular Stocks